Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
15/10/2020 - 3 minutes
News
Spatial Transcriptomics Landscape Shifts With Two Major Acquisitions
The Swedish firm Cartana and US-based ReadCoor have recently been snapped up by the US…
14/10/2020 - 4 minutes
2020 Chemistry Nobel Prize Awarded to CRISPR-Cas9 Pioneers
The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing…
09/10/2020 - 4 minutes
EU Establishes €250M Fund to Scale up Bioeconomy Companies
The European Investment Bank (EIB) is backing a huge €250M fund to help bioeconomy companies…
08/10/2020 - 4 minutes
Investment Is Pouring Into Neuromodulation Treatments
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which…
07/10/2020 - 6 minutes
Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
05/10/2020 - 5 minutes
Huge €62M Series B Boost for Mosa Meat’s Cell-Based Burgers
The Netherlands-based food technology company Mosa Meats has raised €62M in a Series B round…
02/10/2020 - 3 minutes
Medicxi to Shake up the Biotech VC Investment Model with €200M Fund
UK-based investment firm Medicxi aims to attract more investors to the life sciences with a…
01/10/2020 - 4 minutes
How Will AC Immune’s Phase II Fail Impact Alzheimer’s Research?
AC Immune and Genentech’s drug has failed to slow the progression of Alzheimer’s disease in…
29/09/2020 - 6 minutes
Roche Confirms Pharma Appetite for Inflammatory Disease Treatments
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…
25/09/2020 - 4 minutes
3D Bioprinting Gains a Foothold in Biomedicine
3D printing has revolutionized manufacturing by reducing costs and giving designers and engineers immense flexibility.…
17/09/2020 - 5 minutes
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
14/09/2020 - 3 minutes
